Pill – Today Stock Markets News

FDA says Novo Nordisk’s obesity pill TV ad includes misleading claims

Hims & Hers pulls copycat weight-loss pill after legal threats

Novo Nordisk shares rise after Wegovy obesity pill launch

First GLP-1 pill for obesity from Novo Nordisk launches in the U.S.

FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk

Genentech launches direct to consumer program for flu pill Xofluza

Eli Lilly plans $6.5 billion Texas manufacturing plant for obesity pill

Eli Lilly’s obesity pill will rival Novo Nordisk’s oral Wegovy drug

Eli Lilly obesity pill orforglipron led to 12% weight loss